Gates Foundation will provide $120 million to ensure generic production of Merck’s Covid-19 pill This suggests Merck will profit handsomely from sales to wealthy nations, but its licensing deals will not ensure sufficient access, according to Brook Baker, a Northeastern University professor who specializes in access to medicines and intellectual property and a senior policy analyst for Health GAP. “There are three positives here: more efficient manufacturing that can lead […]